Go Red for Women’s Heart Health

Heart disease is the most common cause of death in women.
We stand with laboratories and clinicians in their fight against heart disease, and we support the
American Heart Association’s Go Red for Women initiative to bring equity to heart health research and care.

Women are underrepresented in research and clinical trials. Because of this gap, physicians lack important information about how women might respond differently to heart disease, have different symptoms and need different diagnostic approaches and treatments.1

Heart disease can be a silent condition until the occurrence of a heart attack, but diagnosing a heart attack in women can be challenging. This is because women experiencing a heart attack sometimes do not exhibit the same symptoms as men. For example, women are more likely than men to experience symptoms like nausea and shortness of breath, which can lead to mistaken or delayed diagnoses. Seemingly atypical presentations like these place even more diagnostic importance on the results of a blood test in identifying acute myocardial infarction (AMI).


Advance emergency cardiac care for patients

Access hsTnI is the only high-sensitivity Troponin I assay with sex-specific cutoff values, so physicians can accurately identify ≥94% of men and women with AMI.

Discover new opportunities in emergency care

Learn more about high-sensitivity assays and find out from accomplished acute-disease researcher Louise Cullen how to implement them into clinical care.

Access hsTnI assay features excellent low-end sensitivity

Discover how we are supporting our communities in their effort to advance healthcare for all.

1”Health Equity,” American Heart Association, https://www.goredforwomen.org/en/get-involved/health-equity. Accessed 3 Feb 2019.